CD63 and central nervous system cancer: The flow cytometric assay revealed good levels of signals for the tetraspanin molecule CD63 tested as exosomal marker on vesicles derived from different-grade glioma patients (grade I, II, III), and the same proteins were detected by flow cytometry in control sample (healthy individuals).